Published in Lab Business Week, September 30th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Nektar Therapeutics.
Report 1: Nektar Therapeutics (NASDAQ:NKTR) announced the appointment of Tim Harkness as Senior Vice President and CFO. Harkness reports to Nektar President and CEO Howard W. Robin, and will serve as an integral member of the company's new management team.
"With his strong understanding of healthcare and finance, Tim is a critical addition to the leadership team at Nektar," Robin said. "He brings significant experience in both financial management and strategic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week